These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 7602188)
1. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan]. Nunoue T Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188 [TBL] [Abstract][Full Text] [Related]
2. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Pereira RF; Paula WN; Cubel Rde C; Nascimento JP Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423 [TBL] [Abstract][Full Text] [Related]
3. Use of recombinant human parvovirus B19 antigens in serological assays. Cubie HA; Leslie EE; Smith S; O'Neill HJ; Hart H; Cohen BJ; Inglis JM J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436 [TBL] [Abstract][Full Text] [Related]
4. [Serological diagnosis for human parvovirus B19 infection by an enzyme immunoassay kit with recombinant antigens synthesized in a baculovirus expression system]. Yoto Y; Kudoh T; Haseyama K; Chiba S; Matsunaga Y; Yamazaki S Kansenshogaku Zasshi; 1995 Oct; 69(10):1135-40. PubMed ID: 7499916 [TBL] [Abstract][Full Text] [Related]
5. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. Erdman DD; Usher MJ; Tsou C; Caul EO; Gary GW; Kajigaya S; Young NS; Anderson LJ J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775 [TBL] [Abstract][Full Text] [Related]
6. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. Gray JJ; Cohen BJ; Desselberger U J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275 [TBL] [Abstract][Full Text] [Related]
7. [Sero-diagnosis for human parvovirus B19 infection by IgM and IgG antibody capture method of enzyme-linked immunosorbent assay--study on an epidemic case of erythema infectiosum]. Matsunaga Y; Yamazaki S; Moritsugu Y; Kuwabara Y; Nishigaki M Kansenshogaku Zasshi; 1992 Apr; 66(4):434-40. PubMed ID: 1624835 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection. Chen MY; Lee KL; Hung CC J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva. Cubel RC; Oliveira SA; Brown DW; Cohen BJ; Nascimento JP J Clin Microbiol; 1996 Jan; 34(1):205-7. PubMed ID: 8748306 [TBL] [Abstract][Full Text] [Related]
10. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay. Salimans MM; van Bussel MJ; Brown CS; Spaan WJ J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069 [TBL] [Abstract][Full Text] [Related]
11. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies. Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687 [TBL] [Abstract][Full Text] [Related]
12. A recombinant immunoblot and ELISA for detection of acute parvovirus B19 infection. Schwarz TF; Jäger G Zentralbl Bakteriol; 1994 Mar; 280(4):526-33. PubMed ID: 8061414 [TBL] [Abstract][Full Text] [Related]
13. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. Brown CS; van Bussel MJ; Wassenaar AL; van Elsacker-Niele AM; Weiland HT; Salimans MM J Virol Methods; 1990 Jul; 29(1):53-62. PubMed ID: 2170436 [TBL] [Abstract][Full Text] [Related]
14. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. Kerr S; O'Keeffe G; Kilty C; Doyle S J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405 [TBL] [Abstract][Full Text] [Related]
15. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients]. Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265 [TBL] [Abstract][Full Text] [Related]
16. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623 [TBL] [Abstract][Full Text] [Related]
18. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy. Dobec M; Juchler A; Flaviano A; Kaeppeli F Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737 [TBL] [Abstract][Full Text] [Related]
19. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays. Rice PS; Cohen BJ Epidemiol Infect; 1996 Jun; 116(3):331-8. PubMed ID: 8666078 [TBL] [Abstract][Full Text] [Related]
20. Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins. Palmer P; Pallier C; Leruez-Ville M; Deplanche M; Morinet F Clin Diagn Lab Immunol; 1996 Mar; 3(2):236-8. PubMed ID: 8991644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]